Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
Marketed by Galderma Laboratories, L.P., Differin® (adapalene 0.3% topical gel) is a safe and effective topical therapy used for the treatment of acne vulgaris. Actavis Mid-Atlantic LLC has developed a generic formulation of adapalene 0.3% topical gel and the current study is designed to evaluate the safety and efficacy of this formulation.
Epistemonikos ID: 55465162c717b82cd9f9f53e6d64903373933b7f
First added on: May 05, 2024